Neonatal Group B Streptococcal Infection in Australia: A Case-control Study.
Date
2023
Authors
Yanni, M.
Stark, M.
Francis, L.
Francis, J.R.
McMillan, M.
Baird, R.
Heath, P.T.
Gordon, A.
Riccardione, J.
Wilson, A.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Pediatric Infectious Disease Journal, 2023; 42(5):429-435
Statement of Responsibility
Marianne Yanni, Michael Stark, Laura Francis, Joshua R. Francis, Mark McMillan, Rob Baird, Paul T. Heath, Alex Gordon, James Riccardione, Angela Wilson, Rebecca Lee, Kathrina Chooi, Olivia-Paris Quinn, and Helen S. Marshall
Conference Name
Abstract
BACKGROUND: To determine maternal and neonatal risk factors for, and incidence of, neonatal early-onset group B streptococcus (EOGBS) and late-onset (LOGBS) infection in South Australia (SA) and the Northern Territory (NT). METHODS: A case-control study with 2:1 matched controls to cases. The study included tertiary hospitals in South Australia and the Northern Territory, Australia. Retrospective data were collected from a 16-year epoch (2000-2015). RESULTS: Of a total of 188 clinically suspected or confirmed cases, 139 were confirmed, of which 56.1% (n = 78) were EOGBS and 43.9% (n = 61) were LOGBS. The incidence of clinically suspected and confirmed cases of EOGBS was 0.26/1000 live births in SA and 0.73/1000 live births in the NT, and the incidence of confirmed cases was 0.19/1000 for SA and 0.36/1000 for the NT. The incidence of clinically suspected or confirmed LOGBS was 0.18/1000 live births in SA and 0.16/1000 for the NT. The majority of infants with GBS presented with sepsis, pneumonia, or meningitis. Developmental delay was the most commonly recorded long-term complication at 1 year old. Risk factors for EOGBS included maternal GBS carriage, previous fetal death, identifying as Aboriginal and/or Torres Strait Islander, and maternal fever in labor/chorioamnionitis. CONCLUSIONS: GBS remains a leading cause of neonatal morbidity and mortality. Adding previous fetal death to GBS screening guidelines would improve GBS prevention. The introduction of maternal GBS vaccination programs should be guided by country-specific disease epidemiology.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.